StockWatch: MacroGenics Shares Crater after Trial Deaths
MacroGenics president and CEO Scott Koenig, MD, PhD
MacroGenics (MGNX) shares cratered 77% on Friday, a day after the company acknowledged the deaths of five patients—three of them potentially treatment-related—in the company’s Phase II TAMARACK...
CSUFT-led team creates novel flame-retardant, smoke-suppressing, and superhydrophobic transparent bamboo for future glasses
Professors Yiqiang Wu and Caichao Wan, along with their team from Central South University of Forestry and Technology (CSUFT), have pioneered a groundbreaking transparent material derived from natural bamboo. This innovative material features a...
Study traces an infectious language epidemic
“Sticks and stones may break my bones,” the old adage goes. “But words will never hurt me.”
Credit: Photo by Peter Means for Virginia Tech.
“Sticks and stones may break my bones,” the old adage goes....
Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy
“These results argue that combinations based on immunotherapy may also provide an opportunity for targeting urothelial cancers with low TMB, and provide efficacy superior to classic chemotherapy.”
Credit: 2024 Voutsadakis.
“These results argue that combinations based...
During peak of COVID-19 some lacked access to safe water and lavatories
A defining development of the 20th century that changed the course of public health was when governments around the world improved access to safe water, sanitation and hygiene. However, a binational study led by...
Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Imitation is not just the sincerest form of flattery. When combined with machine learning, molecular mimicry is how Metaphore Biotechnologies designs novel treatments in autoimmune disease, oncology—and metabolic disorders, the therapeutic area of its...
ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Kate Therapeutics’ CSO and scientific co-founder, Sharif Tabebordbar, PhD, will present detailed preclinical efficacy and safety results in nonhuman primates (NHPs) on its product pipeline and platform at the ASGCT 2024 Annual Meeting in...
New insight into genesis of spina bifida
A group of researchers at the University of California San Diego School of Medicine led an investigation that offers new insight into the causes of spina bifida, the most common structural disorder of the...
Broken String-Crick Institute Collaboration Focuses on ALS Research
Broken String Biosciences, a gene therapy company based in Cambridge, U.K., has announced a new research collaboration with the Francis Crick Institute in London. The Crick Institute’s researchers plan to leverage Broken String’s DNA...
AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy
Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies. Combined with additional algorithms, the predictive model,...
